Lynne F. McGrath - Mar 28, 2022 Form 4/A - Amendment Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: Director
Signature: /s/ Lynne F. McGrath
Stock symbol: ALZN
Transactions as of: Mar 28, 2022
Transactions value $: -$30,325
Form type: 4/A - Amendment
Date filed: 4/8/2022, 05:00 PM
Date Of Original Report: Apr 6, 2022
Previous filing: Mar 15, 2022
Next filing: Mar 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALZN	Common Stock	Sale	-$30.3K	-25K	-25%	$1.21	75K	Mar 28, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from "A" to "D".
F2	The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

Content

The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from "A" to "D".

The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.